AAR has also been found to be able to serve as a biomarker for the identification and early prediction of HCC recurrence [9–11], leading to it being proposed as an effective marker for AFP-negative HCC (AFP-NHCC) [12]. Here, AFP is linked to hepatocellular carcinoma.